A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer, Early Breast Cancer
Interventions: OTHER: No intervention
Sponsor: Hoffmann-La Roche